Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (22.528)

101

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system

enthalten in: Scientific reports | 2024

von Malden, D. | McLaughlin, J. | Hong, V. | +8

102

Insights from a community-based survey on factors Influencing Acceptance and Uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 Antiviral Medication in Singapore

enthalten in: ResearchSquare.com | 2024

von Soh, S. | Ong, W. | Thein, T. | +2

103

A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco : A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics Among COVID-19 Patients Receiving Treatment With Nirmatrelvir/Ritonavir (PAXLOVIDTM) in Morocco.

enthalten in: ClinicalTrials.gov | 2024

104

Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea : a retrospective cohort study

enthalten in: Osong public health and research perspectives | 2024

von Kim, D. | Yoo, M. | Kim, N. | +5

105

Evaluating Nirmatrelvir-Ritonavir (Paxlovid®) in Outpatient COVID-19 Treatment: Safety, Tolerability, and Adherence Insights from Primary Healthcare Clinics

enthalten in: ResearchSquare.com | 2024

von Zaharuddin, Z. | Hus, N. | Karuppannan, M.

106

A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir : AN INTERVENTIONAL, EFFICACY AND SAFETY, PHASE 2, RANDOMIZED, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE A REPEAT 5-DAY COURSE OF NIRMATRELVIR/RITONAVIR COMPARED TO PLACEBO/RITONAVIR IN PARTICIPANTS AT LEAST 12 YEARS OF AGE WITH REBOUND OF COVID-19 SYMPTOMS AND RAPID ANTIGEN TEST POSITIVITY

enthalten in: ClinicalTrials.gov | 2024

107

Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease

enthalten in: Expert review of anti-infective therapy | 2024

von Chen, C. | Huang, C. | Wu, J. | +12

108

COVID-19 Therapeutics Use by Social Deprivation in England, July 2020–April 2023

enthalten in: Preprints.org | 2024

von Falola, A. | Squire, H. | Bou-Antoun, S. | +3

109

Antiviral Agents Against COVID-19 Infection : Antiviral for Adult Patients Hospitalized for SARS-CoV-2 Infection: a Randomized, Phase 2/3, Multicenter, Placebo Controlled, Adaptive, Multi-arm, Multi-stage Clinical Trial - Coalition Brazil COVID-19 IX: REVOLUTIOn

enthalten in: ClinicalTrials.gov | 2024

110

Paxlovid for nonhospitalized patients with COVID-19

enthalten in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine | 2024

von Johari, F. | Verma, R.